{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:49:05Z","timestamp":1760402945513,"version":"build-2065373602"},"reference-count":81,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Peritoneal dialysis (PD) is a widely used renal replacement therapy in which hyperosmolar solutions are instilled into the abdominal cavity to facilitate the removal of excess water, electrolytes, and metabolic waste products. During PD treatment, homeostasis is maintained through adaptive responses of the neuroendocrine system to high glucose exposure, changes in circulating blood volume, and shifts in electrolyte balance. Clinical observations and limited experimental studies suggest that these neurohormonal dynamics may influence both the complications and therapeutic efficacy of PD. However, systematic investigations remain scarce, largely because hormonal and neural responses are highly dynamic, involve complex interactions, and are substantially influenced by individual patient characteristics. In this review, we synthesize current clinical and experimental evidence linking PD-related complications with hidden hormone dynamics, with particular emphasis on hypothalamic hormones such as arginine vasopressin. We also discuss how the biocompatibility of PD solutions\u2014traditionally assessed by their effects on peritoneal mesothelial cells\u2014could be reconsidered when neuroendocrine aspects are taken into account. We propose that integrating both clinical insights and emerging basic research will provide a more comprehensive understanding of neuroendocrine regulation in PD and may contribute to the development of novel therapeutic strategies.<\/jats:p>","DOI":"10.3390\/life15101588","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:13:27Z","timestamp":1760361207000},"page":"1588","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hidden Impacts of Peritoneal Dialysis on the Endocrine System"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-2099","authenticated-orcid":false,"given":"Hiromichi","family":"Ueno","sequence":"first","affiliation":[{"name":"Department of the Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"},{"name":"Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ueta","sequence":"additional","affiliation":[{"name":"Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5501-2477","authenticated-orcid":false,"given":"Jun-ichiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of the Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-8831","authenticated-orcid":false,"given":"Takashi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5843-9663","authenticated-orcid":false,"given":"Tetsu","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of the Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of the Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"ref_1","first-page":"275","article-title":"Hormonal Changes in Uremia","volume":"11","author":"Bonomini","year":"1979","journal-title":"Clin. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000169927","article-title":"Endocrine Abnormalities in Patients Treated by Continuous Ambulatory Peritoneal Dialysis","volume":"8","author":"Maher","year":"1990","journal-title":"Blood Purif."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kang, S.H., Choi, E.W., Park, J.W., Cho, K.H., and Do, J.Y. (2016). Clinical Significance of the Edema Index in Incident Peritoneal Dialysis Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147070"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3747\/pdi.2014.00008","article-title":"The Effect of Fluid Overload on Clinical Outcome in Southern Chinese Patients Undergoing Continuous Ambulatory Peritoneal Dialysis","volume":"35","author":"Guo","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3747\/pdi.2013.00074","article-title":"Encapsulating Peritoneal Sclerosis in the Era of a Multi-Disciplinary Approach Based on Biocompatible Solutions: The NEXT-PD Study","volume":"34","author":"Nakayama","year":"2014","journal-title":"Perit. Dial. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease","volume":"13","author":"Williams","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hashimoto, K., and Kamijo, Y. (2025). Current Progress in Peritoneal Dialysis: A Narrative Review of Progress in Peritoneal Dialysis Fluid. Life, 15.","DOI":"10.3390\/life15020279"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000093510","article-title":"Is There a Competition between Urine Volume and Peritoneal Ultrafiltration in Peritoneal Dialysis Patients?","volume":"150","author":"Kooman","year":"2006","journal-title":"Contrib. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tian, N., Guo, Q., Zhou, Q., Cao, P., Hong, L., Chen, M., Yang, X., and Yu, X. (2016). The Impact of Fluid Overload and Variation on Residual Renal Function in Peritoneal Dialysis Patient. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153115"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a Fragment of the Vasopressin Precursor, as a Novel Predictor of Outcome in Heart Failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e12603","DOI":"10.1111\/jne.12603","article-title":"Up-Regulation of Hypothalamic Arginine Vasopressin by Peripherally Administered Furosemide in Transgenic Rats Expressing Arginine Vasopressin-Enhanced Green Fluorescent Protein","volume":"30","author":"Ueno","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2019.02.027","article-title":"Neuropathic Pain Up-Regulates Hypothalamo-Neurohypophysial and Hypothalamo-Spinal Oxytocinergic Pathways in Oxytocin-Monomeric Red Fluorescent Protein 1 Transgenic Rat","volume":"406","author":"Nishimura","year":"2019","journal-title":"Neuroscience"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1152\/ajpregu.00107.2021","article-title":"AVP-eGFP Was Significantly Upregulated by Hypovolemia in the Parvocellular Division of the Paraventricular Nucleus in the Transgenic Rats","volume":"322","author":"Sanada","year":"2022","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ueno, H., Ueta, Y., Nonaka, Y., Shirouzu, T., Ikeda, N., Furuno, I., Nakazono, K., Hasegawa, E., Shimizu, M., and Koga, J. (2025). Effects of Peritoneal Dialysis Fluids on Arginine Vasopressin Dynamics in Humans and Transgenic Rats. Perit. Dial. Int., 8968608251347093.","DOI":"10.1177\/08968608251347093"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10157-013-0883-8","article-title":"Tolvaptan Increases Urine and Ultrafiltration Volume for Patients with Oliguria Undergoing Peritoneal Dialysis","volume":"18","author":"Iwahori","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1093\/ndt\/gfs075","article-title":"Hypoalbuminaemia, Systemic Albumin Leak and Endothelial Dysfunction in Peritoneal Dialysis Patients","volume":"27","author":"Yu","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","first-page":"604","article-title":"Plasma 18-Hydroxycorticosterone during Continuous Ambulatory Peritoneal Dialysis","volume":"102","author":"Zager","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"ref_18","first-page":"147","article-title":"Increased Levels of Plasma Renin, Aldosterone, Catecholamines and Vasopressin in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients","volume":"28","author":"Zabetakis","year":"1987","journal-title":"Clin. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients","volume":"25","author":"Ito","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an Angiotensin-Converting Enzyme Inhibitor on Residual Renal Function in Patients Receiving Peritoneal Dialysis. A Randomized, Controlled Study","volume":"139","author":"Li","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e14558","DOI":"10.14814\/phy2.14558","article-title":"Oxytocin-Monomeric Red Fluorescent Protein 1 Synthesis in the Hypothalamus under Osmotic Challenge and Acute Hypovolemia in a Transgenic Rat Line","volume":"8","author":"Ueno","year":"2020","journal-title":"Physiol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.1073\/pnas.90.21.10380","article-title":"Central Oxytocin Inhibition of Salt Appetite in Rats: Evidence for Differential Sensing of Plasma Sodium and Osmolality","volume":"90","author":"Blackburn","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/joe.0.1410059","article-title":"The Effect of Vasopressin and Oxytocin on Glomerular Filtration Rate in the Conscious Rat: Contribution to the Natriuretic Response","volume":"141","author":"Forsling","year":"1994","journal-title":"J. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.94.21.11704","article-title":"Oxytocin Releases Atrial Natriuretic Peptide by Combining with Oxytocin Receptors in the Heart","volume":"94","author":"Gutkowska","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/joe.0.1650019","article-title":"Contribution of Endogenous Oxytocin to Sodium Excretion in Anaesthetized, Surgically Operated Rats","volume":"165","author":"Walter","year":"2000","journal-title":"J. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1634\/stemcells.2008-0127","article-title":"Oxytocin Controls Differentiation of Human Mesenchymal Stem Cells and Reverses Osteoporosis","volume":"26","author":"Elabd","year":"2008","journal-title":"Stem Cells"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/ndt\/gfh413","article-title":"Antidiuretic Action of Oxytocin Is Associated with Increased Urinary Excretion of Aquaporin-2","volume":"19","author":"Joo","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1536\/ihj.15-517","article-title":"Heart Failure as a Disruption of Dynamic Circulatory Homeostasis Mediated by the Brain","volume":"57","author":"Kishi","year":"2016","journal-title":"Int. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1681.2004.04002.x","article-title":"Differential Neural Control of Glomerular Ultrafiltration","volume":"31","author":"Denton","year":"2004","journal-title":"Clin. Exp. Pharma. Physio."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.2215\/CJN.06970711","article-title":"Sympathetic Nerve Traffic and Asymmetric Dimethylarginine in Chronic Kidney Disease","volume":"6","author":"Grassi","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kaur, J., Young, B.E., and Fadel, P.J. (2017). Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081682"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","article-title":"Renal Afferent Denervation Prevents the Progression of Renal Disease in the Renal Ablation Model of Chronic Renal Failure in the Rat","volume":"26","author":"Campese","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuroscience.2015.07.055","article-title":"Uric Acid, Indoxyl Sulfate, and Methylguanidine Activate Bulbospinal Neurons in the RVLM via Their Specific Transporters and by Producing Oxidative Stress","volume":"304","author":"Oshima","year":"2015","journal-title":"Neuroscience"},{"key":"ref_34","first-page":"769","article-title":"Gastrointestinal Hormone Profile in Renal Insufficiency","volume":"54","author":"Owyang","year":"1979","journal-title":"Mayo Clin. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000123111","article-title":"Paraventricular Nucleus: A Site for the Integration of Neuroendocrine and Autonomic Mechanisms","volume":"31","author":"Swanson","year":"1980","journal-title":"Neuroendocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2400","article-title":"Central Mechanisms of Osmosensation and Systemic Osmoregulation","volume":"9","author":"Bourque","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1113\/jphysiol.2010.191940","article-title":"Hyperosmotic Activation of CNS Sympathetic Drive: Implications for Cardiovascular Disease","volume":"588","author":"Toney","year":"2010","journal-title":"J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ekir.2023.01.040","article-title":"Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis","volume":"8","author":"Wijewickrama","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1681\/ASN.2004100842","article-title":"Chronic Kidney Disease Causes Defects in Signaling through the Insulin Receptor Substrate\/Phosphatidylinositol 3-Kinase\/Akt Pathway: Implications for Muscle Atrophy","volume":"17","author":"Bailey","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kezi\u0107, A., Gaji\u0107, S., Ostoji\u0107, A.R., Beki\u0107, I., Bonti\u0107, A., Pavlovi\u0107, J., Barali\u0107, M., and Popovi\u0107, L. (2025). Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring. Life, 15.","DOI":"10.3390\/life15050798"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3747\/pdi.2015.00251","article-title":"New-Onset Diabetes in Peritoneal Dialysis Patients\u2014Which Predictors Really Matter?","volume":"36","author":"Rivara","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.ajkd.2007.01.018","article-title":"New-Onset Hyperglycemia in Nondiabetic Chinese Patients Started on Peritoneal Dialysis","volume":"49","author":"Szeto","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/ndt\/gfz116","article-title":"New-Onset Glucose Disorders in Peritoneal Dialysis Patients: A Meta-Analysis and Systematic Review","volume":"35","author":"Xue","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1177\/089686080902902S28","article-title":"Insulin Resistance and Glucose Homeostasis in Peritoneal Dialysis","volume":"29","author":"Fortes","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/ndt\/gfq557","article-title":"Trimestral Variations of C-Reactive Protein, Interleukin-6 and Tumour Necrosis Factor-\u03b1 Are Similarly Associated with Survival in Haemodialysis Patients","volume":"26","author":"Meuwese","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting","volume":"20","author":"Zhang","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"P-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000223791","article-title":"Systemic and Local Inflammation in Peritoneal Dialysis: Mechanisms, Biomarkers and Effects on Outcome","volume":"163","author":"Cordeiro","year":"2009","journal-title":"Contrib. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of Oral N-Acetylcysteine Treatment on Plasma Inflammatory and Oxidative Stress Markers in Peritoneal Dialysis Patients: A Placebo-Controlled Study","volume":"30","author":"Nascimento","year":"2010","journal-title":"Perit. Dial. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.2659","article-title":"Systematic Literature Review of Insulin Dose Adjustments When Initiating Hemodialysis or Peritoneal Dialysis","volume":"42","author":"Blaine","year":"2022","journal-title":"Pharmacotherapy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1210\/jcem-61-6-1205","article-title":"Low Dose Adrenocorticotropin Infusion in Continuous Ambulatory Peritoneal Dialysis Patients","volume":"61","author":"Zager","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbrc.2019.09.039","article-title":"Relay of Peripheral Oxytocin to Central Oxytocin Neurons via Vagal Afferents for Regulating Feeding","volume":"519","author":"Iwasaki","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/cs0690449","article-title":"Twenty-Four Hour Hormonal and Metabolic Profiles in Uraemic Patients before and during Treatment with Continuous Ambulatory Peritoneal Dialysis","volume":"69","author":"Heaton","year":"1985","journal-title":"Clin. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5551\/jat.RV22006","article-title":"Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD","volume":"30","author":"Yamada","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/ndt\/gfl257","article-title":"Mineral Metabolism and Cardiovascular Morbidity and Mortality Risk: Peritoneal Dialysis Patients Compared with Haemodialysis Patients","volume":"21","author":"Noordzij","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/089686080802800621","article-title":"Bone Mineral Density, Vascular Calcifications, and Arterial Stiffness in Peritoneal Dialysis Patients","volume":"28","author":"Adragao","year":"2008","journal-title":"Perit. Dial. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41100-019-0200-4","article-title":"Mineral Bone Disorders (MBD) in Patients on Peritoneal Dialysis","volume":"5","author":"Nitta","year":"2019","journal-title":"Ren. Replace. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ki.1982.110","article-title":"Minerals, Vitamin D, and Parathyroid Hormone in Continuous Ambulatory Peritoneal Dialysis","volume":"21","author":"Delmez","year":"1982","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/089686088700700106","article-title":"Renal Osteodystrophy in Patients on Continuous Ambulatory Peritoneal Dialysis: A Five Year Study","volume":"7","author":"Rahman","year":"1987","journal-title":"Perit. Dial. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/089686088500500115","article-title":"Effects of Continuous Ambulatory Peritoneal Dialysis (CAPD) on Renal Osteodystrophy","volume":"5","author":"Loschiavo","year":"1985","journal-title":"Perit. Dial. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2215\/CJN.04290511","article-title":"Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis","volume":"6","author":"Isakova","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s11255-017-1605-z","article-title":"Hemodialysis Is Associated with Higher Serum FGF23 Level When Compared with Peritoneal Dialysis","volume":"49","author":"Bi","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"ref_64","first-page":"250","article-title":"Plasma Calcitonin Concentration in Patients Treated with Chronic Dialysis: Differences between Hemodialysis and CAPD","volume":"19","author":"Miguel","year":"1983","journal-title":"Clin. Nephrol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1038\/ncomms5082","article-title":"Oxytocin Is an Age-Specific Circulating Hormone That Is Necessary for Muscle Maintenance and Regeneration","volume":"5","author":"Elabd","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/endo.134.3.8119150","article-title":"Dexamethasone Stimulates Osteoclast-like Cell Formation by Inhibiting Granulocyte-Macrophage Colony-Stimulating Factor Production in Mouse Bone Marrow Cultures","volume":"134","author":"Shuto","year":"1994","journal-title":"Endocrinology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.xkme.2021.01.011","article-title":"Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region","volume":"3","author":"Li","year":"2021","journal-title":"Kidney Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/ki.1983.88","article-title":"Influence of Continuous Ambulatory Peritoneal Dialysis on the Anemia of Endstage Renal Disease","volume":"23","author":"Schelstraete","year":"1983","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.1983.tb01512.x","article-title":"Haemoglobin Concentration and Serum Erythropoietin in Renal Dialysis and Transplant Patients","volume":"30","author":"Summerfield","year":"1983","journal-title":"Scand. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/CNP74209","article-title":"Clinical Impact of a Combined Therapy of Peritoneal Dialysis and Hemodialysis","volume":"74","author":"Matsuo","year":"2010","journal-title":"Clin. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI110154","article-title":"Effect of Parathyroid Hormone on Erythropoiesis","volume":"67","author":"Meytes","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in Uremia","volume":"328","author":"Rao","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.surg.2008.07.026","article-title":"Effect of Parathyroidectomy on Anemia and Erythropoietin Dosing in End-Stage Renal Disease Patients with Hyperparathyroidism","volume":"144","author":"Trunzo","year":"2008","journal-title":"Surgery"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and Functional Iron Deficiency Regulate Fibroblast Growth Factor 23 Production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","article-title":"FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis","volume":"289","author":"Coe","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1096\/fj.201700667R","article-title":"Inhibition of Fibroblast Growth Factor 23 (FGF23) Signaling Rescues Renal Anemia","volume":"32","author":"Agoro","year":"2018","journal-title":"FASEB J."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Czaya, B., and Faul, C. (2019). The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174195"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"eaao1632","DOI":"10.1126\/scitranslmed.aao1632","article-title":"Vasopressin Stimulates the Proliferation and Differentiation of Red Blood Cell Precursors and Improves Recovery from Anemia","volume":"9","author":"Mayer","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Schill, F., Engstr\u00f6m, G., Melander, O., Timpka, S., and Enh\u00f6rning, S. (2024). The Possible Role of the Vasopressin System in Hematopoiesis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-55772-5"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"108100","DOI":"10.1016\/j.envint.2023.108100","article-title":"Endocrine Disruptors in Dialysis Therapies: A Literature Review","volume":"178","author":"Cambien","year":"2023","journal-title":"Environ. Int."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1588\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:12:31Z","timestamp":1760364751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["life15101588"],"URL":"https:\/\/doi.org\/10.3390\/life15101588","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}